Development and Validation of a Brief Self-Report Scale to Measure Perceived Immune Vulnerability (PIV) in Cancer Population
The PIV scale is a reliable and valid tool for assessing immune vulnerability in patients with cancer and preliminarily offers a convenient approach to monitoring and evaluating their self-reported immunity. Further research is needed to explore the broader utility of this instrument.
Authors
- Susan C. Chimonas (ORCID: https://orcid.org/0000-0002-7742-5950)
- Jun J. J. Mao (ORCID: https://orcid.org/0000-0001-9229-0380)
- Xiaotong Li (ORCID: https://orcid.org/0000-0003-1006-5871)
- Thomas M. Atkinson (ORCID: https://orcid.org/0000-0002-4965-3913)
- Lingyun Sun (ORCID: https://orcid.org/0000-0002-7191-6177)
- J Bawa
- Kaitlin Lampson (ORCID: https://orcid.org/0009-0003-5262-5707)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Xiyuan Hospital (CN)
- National Cancer Centre Singapore (SG)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-20
- DOI
- https://doi.org/10.3390/cancers17223713
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 0.00